Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

GW PHARMACEUTICALS PLC (GWPH) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $218.00 Metrics
OS: 378.5 M -9 % ROE
Market cap: $82.5 B -20 % ROIC
Net cash: $458 M $1.21 per share
EV: $82.1 B

 
TTM Valuation
EBITDA ($51.6) M
EBIT ($65.6) M
EPS ($77.49)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Sep-30-18Sep-30-16
Revenues527.2311.315.412.712.7
            Revenue growth69.3%1921.8%   
Cost of goods sold37.527.26.66.03.8
Gross profit489.7284.18.86.88.9
            Gross margin92.9%91.3%56.9%53.0%70.0%
Selling, general and administrative336.0259.9165.7141.833.2
Research and development205.4142.7 153.7104.4
EBIT-51.8-118.4-303.6-288.8-128.7
            EBIT margin-9.8%-38.0%-1971.6%-2267.4%-1010.6%
Pre-tax income-55.0-9.2-305.4-291.4-92.4
Income taxes3.1-0.2-0.23.8-0.7
            Tax rate 2.0%0.1% 0.8%
Net income-58.1-9.0-305.3-295.2-91.7
            Net margin-11.0%-2.9%-1982.3%-2317.4%-720.3%
 
Diluted EPS($0.15)($0.02)($0.88)($0.88)($0.34)
Shares outstanding (diluted)375.6371.6347.1333.9272.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy